Hi Primaus72
Just to confirm the 6 week data is the same data and therefore same patients from the 2 phase 3 trials. It is just the first check point from the 2 trials data set.
You will see the chart in the investor presentation they did in June.
PXS just need to prove that the data first taken at 6 weeks is a reliable indication of how you respond over the next 6 months. If they can do that then it removes all arguments in so far as
1) You agree with the EMEA what the improvement needs to be at 6 weeks to stay on the drug. This can be FEV1 of any % or a mixture of FEV1 and reduced infections.
2) It removes all age variabilty as only those who respond to point 1 above stay on the drug.
3) Safety issues are reduced because again non responders drop out after 6 weeks treatment so the benefit of those who stay on the drug outweighs what appears really to be non safety issues.
Cheers
- Forums
- ASX - By Stock
- SNT
- update
update, page-14
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.3¢ |
Change
0.002(6.45%) |
Mkt cap ! $42.58M |
Open | High | Low | Value | Volume |
3.1¢ | 3.3¢ | 3.1¢ | $340.7K | 10.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 626946 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 258862 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 550000 | 0.032 |
1 | 500000 | 0.031 |
6 | 1933333 | 0.030 |
14 | 3149812 | 0.029 |
5 | 1965714 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 258862 | 2 |
0.034 | 148847 | 2 |
0.036 | 100000 | 2 |
0.037 | 134500 | 1 |
0.038 | 13500 | 1 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online